Literature DB >> 7780978

Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.

Q Peng1, J Moan, L W Ma, J M Nesland.   

Abstract

By using a chemical extraction assay and confocal laser scanning fluorescence microscopy, the kinetic patterns of uptake, elimination, and localization of meso-tetra(hydroxyphenyl)porphine (m-THPP) and its corresponding chlorin (m-THPC) in tumors and various normal tissues of female C3D2/F1 mice bearing CaD2 mammary carcinoma were studied after an i.p. injection of either 5 mg/kg body weight of m-THPP or 1 mg/kg body weight of m-THPC. Moreover, the histological and ultrastructural alterations of the tumors were evaluated after photodynamic therapy (PDT) with m-THPP or m-THPC. The PDT efficacy with m-THPP and m-THPC was also compared. Both m-THPP and m-THPC had a similar kinetic pattern of distribution in the tumors and most normal tissues examined. The concentrations of the dyes in the tissues peaked at 24-48 h after injection. The peak values of the uptake of m-THPP by the tissues were found to decrease in the following order: spleen > urinary tract > kidney > liver > lung > tumor > heart > skin > muscle > brain. However, higher concentrations of m-THPC were taken up by the tumors than by most of the normal tissues studied except for the liver, urinary tract, and skin. m-THPP was mainly localized in the stroma of the tumors, whereas m-THPC was distributed in both vascular interstitium and neoplastic cells of the tumors. Morphological studies showed that PDT with m-THPP resulted in destructive changes in the microvasculature of the tumors, whereas m-THPC-based PDT destroyed both vascular walls and tumor cells of the tumors. The m-THPP-PDT of the tumors was much less efficient than m-THPC-PDT of the tumors, although the dose of m-THPP used was five times higher than that of m-THPC. m-THPP and m-THPC have different efficiency of sensitizing tumors to photodestruction, although they are similar with respect to hydrophobicity. This is likely due to the differences in their intratumoral localization patterns and in their absorption spectra.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780978

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung.

Authors:  D A Groneberg; P R Eynott; F Döring; Q Thai Dinh; T Oates; P J Barnes; K F Chung; H Daniel; A Fischer
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

2.  Immunological detection of N-formylkynurenine in porphyrin-mediated photooxided lens α-crystallin.

Authors:  Marilyn Ehrenshaft; Baozhong Zhao; Usha P Andley; Ronald P Mason; Joan E Roberts
Journal:  Photochem Photobiol       Date:  2011-08-25       Impact factor: 3.421

3.  Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels.

Authors:  Qingtang Lin; Krishnakumar Balasubramanian; Dominic Fan; Sun-Jin Kim; Lixia Guo; Hua Wang; Menashe Bar-Eli; Kenneth D Aldape; Isaiah J Fidler
Journal:  Neoplasia       Date:  2010-09       Impact factor: 5.715

4.  Correlation of subcellular compartmentalization of HPMA copolymer-Mce6 conjugates with chemotherapeutic activity in human ovarian carcinoma cells.

Authors:  Monica Tijerina; Pavla Kopecková; Jindŕich Kopecek
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

5.  Synthesis, Photophysical Properties and Application of New Porphyrin Derivatives for Use in Photodynamic Therapy and Cell Imaging.

Authors:  Prasad G Mahajan; Nilam C Dige; Balasaheb D Vanjare; Abdul Rehman Phull; Song Ja Kim; Seong-Karp Hong; Ki Hwan Lee
Journal:  J Fluoresc       Date:  2018-07-16       Impact factor: 2.217

6.  Design and Synthesis of New Porphyrin Analogues as Potent Photosensitizers for Photodynamic Therapy: Spectroscopic Approach.

Authors:  Prasad G Mahajan; Nilam C Dige; Balasaheb D Vanjare; Chong-Hyeak Kim; Sung-Yum Seo; Ki Hwan Lee
Journal:  J Fluoresc       Date:  2020-02-22       Impact factor: 2.217

7.  Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.

Authors:  S Andrejevic-Blant; C Hadjur; J P Ballini; G Wagnières; C Fontolliet; H van den Bergh; P Monnier
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.

Authors:  J P Rovers; A E Saarnak; A Molina; J J Schuitmaker; H J Sterenborg; O T Terpstra
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

9.  Minimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC.

Authors:  R Hornung; M K Fehr; J Monti-Frayne; B J Tromberg; M W Berns; Y Tadir
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

10.  Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model.

Authors:  A Obwegeser; R Jakober; H Kostron
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.